SecBot SecBot
Insider Cluster (4 insiders) ·Filed Mar 3, 2026

BLFS

BIOLIFE SOLUTIONS INC
NEUTRAL
Impact 3/10
Horizondays Processed8mo ago
Insider cluster: 2 insiders, $12K total
Actionable Insight • Neutral

Monitor for additional insider selling in the next 30 days, if volume increases significantly, it could signal growing concern. For now, this cluster is within normal range and not a trading catalyst.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$20.17
T+0 close · Mar 2, 2026 · via day close
Latest settled
+21.47%
T+60 · $24.50
Vs SPY
+11.15%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 3 $20.17entry
  2. T+1 · 9mo ago +2.48%α +1.72% · $20.67
  3. T+5 · 8mo ago −7.44%α −6.96% · $18.67
  4. T+20 · 8mo ago −5.40%α −1.00% · $19.08
  5. T+60 · 6mo ago +21.47%α +11.15% · $24.50
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Four C-suite executives at BioLife Solutions, including the CFO and Chief Quality and Operations Officer, sold shares in a coordinated open-market transaction on March 3, 2026, totaling $32,728 in value. The sales were small in absolute size and represent a negligible fraction of the company's $998M market cap. This appears to be routine portfolio management rather than a signal of material concern.

Key Financial Metrics

Direction
selling
Total Value
$32.7K
Insiders
4

Key Facts

  • Four C-suite executives sold shares on the same day (March 3, 2026) in open-market transactions.
  • Total value of sales: $32,728 (aggregated across CFO, Chief Quality and Operations, Chief HR Officer, and Chief Marketing Officer).
  • All transactions were coded as 'S' (open-market sale) at $20.74 per share.
  • Total insider sales over the past 30 days amount to $33K, consistent with recent patterns.

Financial Impact

$32,728 in total insider sales, representing 0.0033% of market cap

insider ownershipmarket sentiment

Risk Factors

  • Perception risk: Multiple C-suite sales on the same day may attract speculative attention despite small size.
  • Lack of offsetting insider buying, no purchases in this cluster or recent history.

Market Snapshot

Exchange
Nasdaq

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CONTEXT: Insider Cluster Data (4 trades, 7d window)cluster-BLFS-1772748656000

Track record

15 reports on BLFS

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry price pending
  2. Nov 6, 202610d ago Institutional Cluster Bearish 4/10 No price data
  3. Oct 27, 202620d ago SC 13G/A Neutral 3/10 No price data
  4. Oct 16, 20264w ago 15-12G Neutral 4/10 No price data
  5. Oct 13, 20264w ago EFFECT Neutral 3/10 No price data
  6. Oct 13, 20264w ago EFFECT Neutral 3/10 No price data
  7. Oct 6, 20265w ago 8-K Bullish 7/10 Entry $39.00 No price data
  8. Sep 30, 20266w ago 425 Neutral 4/10 Entry $38.85 No price data
  9. Sep 30, 20266w ago DEFA14A Neutral 4/10 Entry $38.85 No price data
  10. Sep 24, 20267w ago SC 13G Neutral 4/10 Entry $38.58 No price data
Showing 10 of 15

US Market Status

Market Closed · Opens Wed (12h 13m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 5, 2026